Skip to main content
Main navigation
Home
Browse
Upcoming Live
On Demand
Podcasts
All
About Us
Login
Register
Browse
Search by Speaker, Therapeutic Area, Series...
Therapeutic Area
- Any -
Allergies
Cardiovascular
Diabetes
Neurology
Women's Health
Format
- Any -
Upcoming Live Programs
On Demand
Podcast
Accreditation
- Any -
NON-ACCREDITED
CCCEP
CFPC
FMOQ
RCPSC
Series
- Any -
Breaking News
CAN-R³: Canadian Initiative to Reduce Residual Risk
Diabetes Update 2022 - Podcast Series
HF21
Top 3 HF Conundrums
On Demand
59:51
May 10, 2022
A Nephro and Cardio Convo: Common Clinical Questions around Anticoagulation in C
A Nephro and Cardio Convo: Common Clinical Questions around Anticoagulation in CKD
On Demand
August 25, 2023
AIM-LO: PCSK9 inhibition (mAbs and siRNA) - Dosing FAQs
AIM-LO: PCSK9 inhibition (mAbs and siRNA) - Dosing FAQs
On Demand
03:02
July 18, 2023
AIM-LO: Statins + Ezetimibe
AIM-LO: Statins + Ezetimibe
On Demand
03:37
July 18, 2023
AIM-LO: LDL-C: Lower for Longer is Better
AIM-LO: LDL-C: Lower for Longer is Better
On Demand
06:18
July 18, 2023
AIM-LO: PCSK9 inhibition (mAbs and siRNA) - Efficacy & Safety Data
AIM-LO: PCSK9 inhibition (mAbs and siRNA) - Efficacy & Safety Data
On Demand
03:31
July 18, 2023
AIM-LO: Non-HDL Cholesterol: Evolving Evidence Leads to a Novel Strategy
AIM-LO: Non-HDL Cholesterol: Evolving Evidence Leads to a Novel Strategy
On Demand
03:03
July 18, 2023
AIM-LO: Icosapent ethyl (IPE)
AIM-LO: Icosapent ethyl (IPE)
On Demand
06:14
July 18, 2023
AIM-LO: PCSK9 inhibition (mAbs and siRNA) - Mechanisms of Action
AIM-LO: PCSK9 inhibition (mAbs and siRNA) - Mechanisms of Action
On Demand
03:14
July 18, 2023
AIM-LO: Key Tips to Maximize Therapeutic Access for Your Patients
AIM-LO: Key Tips to Maximize Therapeutic Access for Your Patients
On Demand
04:48
July 18, 2023
AIM-LO: Engaging With Your Patients about Selection of Injectable Therapies for
Engaging With Your Patients about Selection of Injectable Therapies for LDL-C Reduction
On Demand
03:14
July 18, 2023
AIM-LO: Overview of 2021 CCS Dyslipidemia Guidelines: Focus Secondary Prevention
AIM-LO: Overview of 2021 CCS Dyslipidemia Guidelines: Focus on Secondary Prevention
On Demand
1 hour
December 5, 2022
The New HFrontier: Worsening Heart Failure
The New HFrontier: Worsening Heart Failure
On Demand
1 Hour
November 28, 2022
On Demand: Hyperkalemia management in Heart Failure Webinar
Watch Now!
On Demand
1 Hour
November 24, 2022
The New HFrontier: ATTR Amyloidosis
Watch Now!
On Demand
1 Hour
November 23, 2022
Une nouvelle frontière
Sur Demande!
On Demand
1 Hour
September 29, 2022
The Present and Future of Anticoagulation
The Present and Future of Anticoagulation Webinar
On Demand
59:58
June 21, 2022
Managing Cancer-Associated Thrombosis
Managing Cancer-Associated Thrombosis
On Demand
58:44
May 31, 2022
Clinical Challenges in Secondary Prevention of CAD
Clinical Challenges in Secondary Prevention of CAD
Pagination
Current page
1
Page
2
Page
3
Next page
››
Last page
Last »
